

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | hemidesmosome assembly (GO:0031581) | 5.85971516 |
| 2 | COPI coating of Golgi vesicle (GO:0048205) | 4.89937559 |
| 3 | Golgi transport vesicle coating (GO:0048200) | 4.89937559 |
| 4 | desmosome organization (GO:0002934) | 4.79039227 |
| 5 | protein localization to endosome (GO:0036010) | 4.35491512 |
| 6 | cell adhesion mediated by integrin (GO:0033627) | 4.33235614 |
| 7 | wound healing, spreading of epidermal cells (GO:0035313) | 4.18611558 |
| 8 | negative regulation of nitric-oxide synthase activity (GO:0051001) | 3.87272929 |
| 9 | cellular response to interferon-alpha (GO:0035457) | 3.76654939 |
| 10 | skin morphogenesis (GO:0043589) | 3.73533265 |
| 11 | endodermal cell differentiation (GO:0035987) | 3.65397353 |
| 12 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.56943557 |
| 13 | protein retention in ER lumen (GO:0006621) | 3.54021376 |
| 14 | wound healing, spreading of cells (GO:0044319) | 3.49039787 |
| 15 | muscle cell migration (GO:0014812) | 3.41558990 |
| 16 | chondrocyte proliferation (GO:0035988) | 3.36338017 |
| 17 | regulation of transforming growth factor beta2 production (GO:0032909) | 3.35541645 |
| 18 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 3.33250408 |
| 19 | * collagen fibril organization (GO:0030199) | 3.26221668 |
| 20 | neutrophil activation involved in immune response (GO:0002283) | 3.25084122 |
| 21 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 3.23200863 |
| 22 | type B pancreatic cell proliferation (GO:0044342) | 3.18322631 |
| 23 | negative regulation of anoikis (GO:2000811) | 3.17570108 |
| 24 | protein maturation by protein folding (GO:0022417) | 3.16147933 |
| 25 | regulation of integrin-mediated signaling pathway (GO:2001044) | 3.15442599 |
| 26 | protein heterotrimerization (GO:0070208) | 3.13807898 |
| 27 | extracellular fibril organization (GO:0043206) | 3.12141072 |
| 28 | nucleotide-sugar biosynthetic process (GO:0009226) | 3.08755975 |
| 29 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 3.06660046 |
| 30 | regulation of interleukin-8 secretion (GO:2000482) | 3.06456175 |
| 31 | regulation of monocyte chemotaxis (GO:0090025) | 3.06028645 |
| 32 | low-density lipoprotein particle clearance (GO:0034383) | 3.04760123 |
| 33 | proteasome assembly (GO:0043248) | 3.03334699 |
| 34 | hypotonic response (GO:0006971) | 3.02182983 |
| 35 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.97415360 |
| 36 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.97413161 |
| 37 | cellular response to zinc ion (GO:0071294) | 2.95483951 |
| 38 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.92738688 |
| 39 | cellular copper ion homeostasis (GO:0006878) | 2.92716058 |
| 40 | cell-substrate junction assembly (GO:0007044) | 2.91843384 |
| 41 | collagen metabolic process (GO:0032963) | 2.90824990 |
| 42 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.89925601 |
| 43 | protein hydroxylation (GO:0018126) | 2.89720044 |
| 44 | COPII vesicle coating (GO:0048208) | 2.87861481 |
| 45 | nucleobase-containing small molecule interconversion (GO:0015949) | 2.87644199 |
| 46 | epithelial cell-cell adhesion (GO:0090136) | 2.86886303 |
| 47 | apoptotic cell clearance (GO:0043277) | 2.85921316 |
| 48 | positive regulation of actin filament depolymerization (GO:0030836) | 2.84478667 |
| 49 | mesenchymal-epithelial cell signaling (GO:0060638) | 2.81193302 |
| 50 | fibril organization (GO:0097435) | 2.80347351 |
| 51 | collagen catabolic process (GO:0030574) | 2.79104429 |
| 52 | negative regulation of keratinocyte proliferation (GO:0010839) | 2.78594495 |
| 53 | negative regulation of fatty acid transport (GO:2000192) | 2.78446038 |
| 54 | extracellular matrix disassembly (GO:0022617) | 2.77721195 |
| 55 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.77124705 |
| 56 | basement membrane organization (GO:0071711) | 2.75707348 |
| 57 | multicellular organismal macromolecule metabolic process (GO:0044259) | 2.74648342 |
| 58 | mesodermal cell differentiation (GO:0048333) | 2.74611856 |
| 59 | regulation of anoikis (GO:2000209) | 2.73329286 |
| 60 | glomerular visceral epithelial cell development (GO:0072015) | 2.72522034 |
| 61 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 2.71943775 |
| 62 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.71811521 |
| 63 | keratinocyte differentiation (GO:0030216) | 2.71589921 |
| 64 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.70986199 |
| 65 | negative regulation of stem cell proliferation (GO:2000647) | 2.70156621 |
| 66 | endothelial cell morphogenesis (GO:0001886) | 2.69999559 |
| 67 | regulation of transforming growth factor beta1 production (GO:0032908) | 2.69776203 |
| 68 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.69302125 |
| 69 | negative regulation of epidermal growth factor-activated receptor activity (GO:0007175) | 2.68781707 |
| 70 | positive regulation of extracellular matrix organization (GO:1903055) | 2.64639657 |
| 71 | lipopolysaccharide biosynthetic process (GO:0009103) | 2.64540402 |
| 72 | pinocytosis (GO:0006907) | 2.63276970 |
| 73 | sprouting angiogenesis (GO:0002040) | 2.63095978 |
| 74 | multicellular organismal catabolic process (GO:0044243) | 2.61416240 |
| 75 | multicellular organismal metabolic process (GO:0044236) | 2.60927442 |
| 76 | regulation of chemokine secretion (GO:0090196) | 2.60616238 |
| 77 | negative regulation of axon extension involved in axon guidance (GO:0048843) | 2.59856918 |
| 78 | ventricular cardiac muscle cell development (GO:0055015) | 2.59700073 |
| 79 | keratinocyte proliferation (GO:0043616) | 2.59227449 |
| 80 | membrane protein ectodomain proteolysis (GO:0006509) | 2.59046627 |
| 81 | positive regulation of osteoblast proliferation (GO:0033690) | 2.58269778 |
| 82 | cell migration involved in heart development (GO:0060973) | 2.57895512 |
| 83 | cellular response to vitamin (GO:0071295) | 2.57523263 |
| 84 | ganglion development (GO:0061548) | 2.57399454 |
| 85 | kidney mesenchyme development (GO:0072074) | 2.56903835 |
| 86 | vesicle coating (GO:0006901) | 2.54507632 |
| 87 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.53367212 |
| 88 | positive regulation of cell junction assembly (GO:1901890) | 2.51562404 |
| 89 | positive regulation of focal adhesion assembly (GO:0051894) | 2.51562404 |
| 90 | peptide cross-linking (GO:0018149) | 2.49952242 |
| 91 | hyaluronan catabolic process (GO:0030214) | 2.48558555 |
| 92 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 2.48527806 |
| 93 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001241) | 2.46698963 |
| 94 | sequestering of extracellular ligand from receptor (GO:0035581) | 2.46657195 |
| 95 | negative regulation of cartilage development (GO:0061037) | 2.46452527 |
| 96 | protein localization to cell surface (GO:0034394) | 2.46009011 |
| 97 | negative regulation of interleukin-8 production (GO:0032717) | 2.45794716 |
| 98 | glomerular epithelial cell development (GO:0072310) | 2.45698940 |
| 99 | nuclear envelope reassembly (GO:0031468) | 2.45184174 |
| 100 | mitotic nuclear envelope reassembly (GO:0007084) | 2.45184174 |
| 101 | regulation of water loss via skin (GO:0033561) | 2.43454918 |
| 102 | positive regulation of epithelial cell migration (GO:0010634) | 2.43390067 |
| 103 | response to gravity (GO:0009629) | 2.43300338 |
| 104 | * membrane raft organization (GO:0031579) | 2.43040881 |
| 105 | barbed-end actin filament capping (GO:0051016) | 2.43014035 |
| 106 | positive regulation of adherens junction organization (GO:1903393) | 2.42784581 |
| 107 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.42177985 |
| 108 | regulation of tight junction assembly (GO:2000810) | 2.42067108 |
| 109 | negative regulation of monooxygenase activity (GO:0032769) | 2.39714072 |
| 110 | hepatocyte apoptotic process (GO:0097284) | 2.38195734 |
| 111 | regulation of branching involved in salivary gland morphogenesis (GO:0060693) | 2.37074597 |
| 112 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.36111232 |
| 113 | response to interferon-alpha (GO:0035455) | 2.35428829 |
| 114 | sequestering of actin monomers (GO:0042989) | 2.33977566 |
| 115 | regulation of mononuclear cell migration (GO:0071675) | 2.33495653 |
| 116 | plasma membrane repair (GO:0001778) | 2.32682184 |
| 117 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.32373856 |
| 118 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.31744814 |
| 119 | glomerular basement membrane development (GO:0032836) | 2.30962733 |
| 120 | intermediate filament organization (GO:0045109) | 2.30598459 |
| 121 | interferon-gamma secretion (GO:0072643) | 2.29491346 |
| 122 | positive regulation of chemokine secretion (GO:0090197) | 2.27817079 |
| 123 | myeloid cell homeostasis (GO:0002262) | 2.27041597 |
| 124 | regulation of metalloenzyme activity (GO:0048552) | 2.26718031 |
| 125 | keratan sulfate catabolic process (GO:0042340) | 2.26697115 |
| 126 | substrate adhesion-dependent cell spreading (GO:0034446) | 2.26414917 |
| 127 | positive regulation of epithelial to mesenchymal transition (GO:0010718) | 2.25563048 |
| 128 | regulation of podosome assembly (GO:0071801) | 2.25514833 |
| 129 | substrate-dependent cell migration (GO:0006929) | 2.23931977 |
| 130 | atrioventricular valve morphogenesis (GO:0003181) | 2.23783775 |
| 131 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.23671246 |
| 132 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 2.23184982 |
| 133 | axon extension involved in axon guidance (GO:0048846) | 2.23184982 |
| 134 | cellular response to vitamin D (GO:0071305) | 2.22543707 |
| 135 | negative regulation of smooth muscle cell migration (GO:0014912) | 2.22374945 |
| 136 | fibroblast migration (GO:0010761) | 2.22242229 |
| 137 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.22232007 |
| 138 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.22168264 |
| 139 | natural killer cell mediated immunity (GO:0002228) | 2.22168264 |
| 140 | regulation of natural killer cell differentiation (GO:0032823) | 2.21065856 |
| 141 | positive regulation of interferon-alpha production (GO:0032727) | 2.20569209 |
| 142 | hair cycle (GO:0042633) | 2.20400536 |
| 143 | molting cycle (GO:0042303) | 2.20400536 |
| 144 | negative regulation of chondrocyte differentiation (GO:0032331) | 2.19798352 |
| 145 | neutrophil activation (GO:0042119) | 2.19564166 |
| 146 | granulocyte activation (GO:0036230) | 2.19516663 |
| 147 | actin filament depolymerization (GO:0030042) | 2.18897429 |
| 148 | virion attachment to host cell (GO:0019062) | 2.18247038 |
| 149 | adhesion of symbiont to host cell (GO:0044650) | 2.18247038 |
| 150 | renal filtration (GO:0097205) | 2.18126571 |
| 151 | peptidyl-proline hydroxylation (GO:0019511) | 2.16501072 |
| 152 | establishment of skin barrier (GO:0061436) | 2.16236515 |
| 153 | regulation of macrophage cytokine production (GO:0010935) | 2.15367257 |
| 154 | platelet aggregation (GO:0070527) | 2.14956799 |
| 155 | positive regulation of p38MAPK cascade (GO:1900745) | 2.14747760 |
| 156 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 2.13540550 |
| 157 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.13160669 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 5.01601360 |
| 2 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 4.84155412 |
| 3 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 4.10039884 |
| 4 | * SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 3.06967703 |
| 5 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.80968728 |
| 6 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.66465660 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.52828950 |
| 8 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.47937341 |
| 9 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 2.44265132 |
| 10 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 2.44265132 |
| 11 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.32460986 |
| 12 | * CLOCK_20551151_ChIP-Seq_293T_Human | 2.28338010 |
| 13 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.27186588 |
| 14 | * CJUN_26792858_Chip-Seq_BT549_Human | 2.24370198 |
| 15 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 2.21473303 |
| 16 | AR_21909140_ChIP-Seq_LNCAP_Human | 2.17441139 |
| 17 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.17232541 |
| 18 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 2.15447046 |
| 19 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.11498351 |
| 20 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 2.10458322 |
| 21 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 2.06383766 |
| 22 | SOX2_20726797_ChIP-Seq_SW620_Human | 2.06289493 |
| 23 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 10.2881874 |
| 24 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.94838695 |
| 25 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.89823519 |
| 26 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.89492947 |
| 27 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.86058215 |
| 28 | * ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.77679384 |
| 29 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.77669169 |
| 30 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.76820500 |
| 31 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.75691547 |
| 32 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.75487244 |
| 33 | * SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.68393826 |
| 34 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.64340821 |
| 35 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.64186543 |
| 36 | * CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.62146276 |
| 37 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.61681944 |
| 38 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.60512186 |
| 39 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.60297426 |
| 40 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.60245029 |
| 41 | * SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.58489023 |
| 42 | * JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.51700291 |
| 43 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.50296725 |
| 44 | ATF3_27146783_Chip-Seq_COLON_Human | 1.49200221 |
| 45 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.49118777 |
| 46 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.47471038 |
| 47 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.44801679 |
| 48 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.44791577 |
| 49 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.44239155 |
| 50 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.43001057 |
| 51 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.43001057 |
| 52 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.41892268 |
| 53 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.39496165 |
| 54 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.38475805 |
| 55 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.36071523 |
| 56 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.35389641 |
| 57 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.34842411 |
| 58 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.34735277 |
| 59 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.31386846 |
| 60 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.31271467 |
| 61 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.30875890 |
| 62 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.28495323 |
| 63 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.28063422 |
| 64 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.26241343 |
| 65 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.24570347 |
| 66 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.21825126 |
| 67 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.20858718 |
| 68 | * HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.19400613 |
| 69 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.18283341 |
| 70 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 1.16922641 |
| 71 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.16654712 |
| 72 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.16443270 |
| 73 | * NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.14220550 |
| 74 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.13606794 |
| 75 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 1.12260756 |
| 76 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.11320396 |
| 77 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.10710330 |
| 78 | * KLF5_25053715_ChIP-Seq_YYC3_Human | 1.09879157 |
| 79 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.09878083 |
| 80 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.08048666 |
| 81 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.06486168 |
| 82 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.05939065 |
| 83 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.05835741 |
| 84 | EOMES_21245162_ChIP-Seq_HESCs_Human | 1.04889262 |
| 85 | * TP53_18474530_ChIP-ChIP_U2OS_Human | 1.04428523 |
| 86 | * TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.04112462 |
| 87 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.04056299 |
| 88 | * ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.03999210 |
| 89 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.02196738 |
| 90 | * GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.01333363 |
| 91 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.00231553 |
| 92 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.00176357 |
| 93 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.99642301 |
| 94 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.98365421 |
| 95 | ELF5_23300383_ChIP-Seq_T47D_Human | 0.98333306 |
| 96 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 0.97968340 |
| 97 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.97966404 |
| 98 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.97691442 |
| 99 | * KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.97417307 |
| 100 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.96007066 |
| 101 | DCP1A_22483619_ChIP-Seq_HELA_Human | 0.94438433 |
| 102 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 0.94253559 |
| 103 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.94042064 |
| 104 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.93763759 |
| 105 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 0.93762323 |
| 106 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.93660789 |
| 107 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 0.92888193 |
| 108 | * TP63_23658742_ChIP-Seq_EP156T_Human | 0.90469998 |
| 109 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 0.90261934 |
| 110 | TP53_16413492_ChIP-PET_HCT116_Human | 0.90231437 |
| 111 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.88715028 |
| 112 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.88706292 |
| 113 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.88394679 |
| 114 | * KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.88244328 |
| 115 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.88116303 |
| 116 | * EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 0.83408304 |
| 117 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.82220394 |
| 118 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.80488960 |
| 119 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.80488960 |
| 120 | * MAF_26560356_Chip-Seq_TH1_Human | 0.79208557 |
| 121 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.78767113 |
| 122 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.76466345 |
| 123 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.76237330 |
| 124 | TP53_22127205_ChIP-Seq_IMR90_Human | 0.74045163 |
| 125 | * PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.73078141 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008438_abnormal_cutaneous_collagen | 4.80789492 |
| 2 | MP0005275_abnormal_skin_tensile | 4.33261809 |
| 3 | MP0003705_abnormal_hypodermis_morpholog | 3.67802572 |
| 4 | MP0003191_abnormal_cellular_cholesterol | 3.15979874 |
| 5 | MP0003566_abnormal_cell_adhesion | 2.89961419 |
| 6 | MP0009780_abnormal_chondrocyte_physiolo | 2.63759490 |
| 7 | MP0004272_abnormal_basement_membrane | 2.62150245 |
| 8 | MP0005503_abnormal_tendon_morphology | 2.60642078 |
| 9 | MP0002060_abnormal_skin_morphology | 2.48397732 |
| 10 | MP0003279_aneurysm | 2.38378762 |
| 11 | MP0001958_emphysema | 2.33466775 |
| 12 | MP0002796_impaired_skin_barrier | 2.25258246 |
| 13 | MP0010352_gastrointestinal_tract_polyps | 2.22406269 |
| 14 | MP0010234_abnormal_vibrissa_follicle | 2.16907271 |
| 15 | MP0005023_abnormal_wound_healing | 2.16132069 |
| 16 | MP0003941_abnormal_skin_development | 1.94102173 |
| 17 | MP0003436_decreased_susceptibility_to | 1.92461071 |
| 18 | MP0006054_spinal_hemorrhage | 1.85976797 |
| 19 | MP0003453_abnormal_keratinocyte_physiol | 1.83531876 |
| 20 | MP0002877_abnormal_melanocyte_morpholog | 1.74183692 |
| 21 | MP0002254_reproductive_system_inflammat | 1.72414756 |
| 22 | MP0005360_urolithiasis | 1.71711947 |
| 23 | MP0003091_abnormal_cell_migration | 1.65966457 |
| 24 | MP0009384_cardiac_valve_regurgitation | 1.63596897 |
| 25 | MP0004947_skin_inflammation | 1.63191255 |
| 26 | MP0003806_abnormal_nucleotide_metabolis | 1.61598577 |
| 27 | MP0001533_abnormal_skeleton_physiology | 1.61586203 |
| 28 | MP0001542_abnormal_bone_strength | 1.56797880 |
| 29 | MP0001216_abnormal_epidermal_layer | 1.55625406 |
| 30 | MP0005623_abnormal_meninges_morphology | 1.54267686 |
| 31 | MP0002148_abnormal_hypersensitivity_rea | 1.51789645 |
| 32 | MP0005501_abnormal_skin_physiology | 1.50782831 |
| 33 | MP0000858_altered_metastatic_potential | 1.46708038 |
| 34 | MP0010030_abnormal_orbit_morphology | 1.44254126 |
| 35 | MP0000749_muscle_degeneration | 1.43818500 |
| 36 | MP0001243_abnormal_dermal_layer | 1.43264452 |
| 37 | MP0005165_increased_susceptibility_to | 1.43228454 |
| 38 | MP0005508_abnormal_skeleton_morphology | 1.38694979 |
| 39 | MP0002282_abnormal_trachea_morphology | 1.38603778 |
| 40 | MP0002933_joint_inflammation | 1.38572037 |
| 41 | MP0005390_skeleton_phenotype | 1.37703962 |
| 42 | MP0009785_altered_susceptibility_to | 1.35552149 |
| 43 | MP0003448_altered_tumor_morphology | 1.35517637 |
| 44 | MP0000343_altered_response_to | 1.33504648 |
| 45 | MP0010771_integument_phenotype | 1.32006031 |
| 46 | MP0000383_abnormal_hair_follicle | 1.31157817 |
| 47 | MP0003724_increased_susceptibility_to | 1.27435468 |
| 48 | MP0001835_abnormal_antigen_presentation | 1.24340911 |
| 49 | MP0002998_abnormal_bone_remodeling | 1.21108399 |
| 50 | MP0009840_abnormal_foam_cell | 1.19902664 |
| 51 | MP0010678_abnormal_skin_adnexa | 1.19402352 |
| 52 | MP0005076_abnormal_cell_differentiation | 1.19082424 |
| 53 | MP0002295_abnormal_pulmonary_circulatio | 1.18796981 |
| 54 | MP0005257_abnormal_intraocular_pressure | 1.16571925 |
| 55 | MP0008004_abnormal_stomach_pH | 1.13792755 |
| 56 | MP0008260_abnormal_autophagy | 1.13407593 |
| 57 | MP0005595_abnormal_vascular_smooth | 1.13017527 |
| 58 | MP0001879_abnormal_lymphatic_vessel | 1.12621544 |
| 59 | MP0003950_abnormal_plasma_membrane | 1.11890813 |
| 60 | MP0009053_abnormal_anal_canal | 1.09923094 |
| 61 | MP0002419_abnormal_innate_immunity | 1.09224357 |
| 62 | MP0003300_gastrointestinal_ulcer | 1.06563295 |
| 63 | MP0000767_abnormal_smooth_muscle | 1.05744386 |
| 64 | MP0000762_abnormal_tongue_morphology | 1.05672710 |
| 65 | MP0005164_abnormal_response_to | 1.04764985 |
| 66 | MP0000733_abnormal_muscle_development | 1.04049241 |
| 67 | MP0003045_fibrosis | 1.03731581 |
| 68 | MP0005197_abnormal_uvea_morphology | 1.03693805 |
| 69 | MP0002896_abnormal_bone_mineralization | 1.03525869 |
| 70 | MP0004233_abnormal_muscle_weight | 1.03047925 |
| 71 | MP0000013_abnormal_adipose_tissue | 1.02778397 |
| 72 | MP0002006_tumorigenesis | 1.02768705 |
| 73 | MP0010368_abnormal_lymphatic_system | 1.00728867 |
| 74 | MP0009250_abnormal_appendicular_skeleto | 1.00513144 |
| 75 | MP0004782_abnormal_surfactant_physiolog | 0.99642058 |
| 76 | MP0005000_abnormal_immune_tolerance | 0.98449294 |
| 77 | MP0002166_altered_tumor_susceptibility | 0.98066993 |
| 78 | MP0000537_abnormal_urethra_morphology | 0.97893330 |
| 79 | MP0002405_respiratory_system_inflammati | 0.97617443 |
| 80 | MP0000377_abnormal_hair_follicle | 0.97499468 |
| 81 | MP0002098_abnormal_vibrissa_morphology | 0.97096846 |
| 82 | MP0005058_abnormal_lysosome_morphology | 0.95095710 |
| 83 | MP0003828_pulmonary_edema | 0.94913916 |
| 84 | MP0001346_abnormal_lacrimal_gland | 0.94532663 |
| 85 | MP0000685_abnormal_immune_system | 0.93774076 |
| 86 | MP0003303_peritoneal_inflammation | 0.93428703 |
| 87 | MP0000750_abnormal_muscle_regeneration | 0.93189574 |
| 88 | MP0003795_abnormal_bone_structure | 0.91128581 |
| 89 | MP0000163_abnormal_cartilage_morphology | 0.90579368 |
| 90 | MP0001849_ear_inflammation | 0.90556715 |
| 91 | MP0002332_abnormal_exercise_endurance | 0.90075767 |
| 92 | MP0010155_abnormal_intestine_physiology | 0.89553520 |
| 93 | MP0005025_abnormal_response_to | 0.89403658 |
| 94 | MP0000751_myopathy | 0.88953639 |
| 95 | MP0001851_eye_inflammation | 0.88648888 |
| 96 | MP0000627_abnormal_mammary_gland | 0.88440264 |
| 97 | MP0001853_heart_inflammation | 0.87449871 |
| 98 | MP0000427_abnormal_hair_cycle | 0.86787647 |
| 99 | MP0009931_abnormal_skin_appearance | 0.86533217 |
| 100 | MP0001191_abnormal_skin_condition | 0.86228060 |
| 101 | MP0000579_abnormal_nail_morphology | 0.85973627 |
| 102 | MP0002115_abnormal_skeleton_extremities | 0.85787387 |
| 103 | MP0000003_abnormal_adipose_tissue | 0.84002991 |
| 104 | MP0002113_abnormal_skeleton_development | 0.83840041 |
| 105 | MP0000647_abnormal_sebaceous_gland | 0.83293495 |
| 106 | MP0005193_abnormal_anterior_eye | 0.83081070 |
| 107 | MP0000467_abnormal_esophagus_morphology | 0.82829806 |
| 108 | MP0005408_hypopigmentation | 0.81963041 |
| 109 | MP0002234_abnormal_pharynx_morphology | 0.81856583 |
| 110 | MP0003075_altered_response_to | 0.81516697 |
| 111 | MP0001790_abnormal_immune_system | 0.81514103 |
| 112 | MP0005387_immune_system_phenotype | 0.81514103 |
| 113 | MP0003186_abnormal_redox_activity | 0.80377209 |
| 114 | MP0004185_abnormal_adipocyte_glucose | 0.79274309 |
| 115 | MP0004883_abnormal_blood_vessel | 0.78519063 |
| 116 | MP0002452_abnormal_antigen_presenting | 0.77876970 |
| 117 | MP0010386_abnormal_urinary_bladder | 0.77197549 |
| 118 | MP0000759_abnormal_skeletal_muscle | 0.75826196 |
| 119 | MP0001915_intracranial_hemorrhage | 0.75649983 |
| 120 | MP0002168_other_aberrant_phenotype | 0.75155903 |
| 121 | MP0001348_abnormal_lacrimal_gland | 0.74726464 |
| 122 | MP0005367_renal/urinary_system_phenotyp | 0.74434774 |
| 123 | MP0000516_abnormal_urinary_system | 0.74434774 |
| 124 | MP0001299_abnormal_eye_distance/ | 0.73922254 |
| 125 | MP0009278_abnormal_bone_marrow | 0.73086268 |
| 126 | MP0005330_cardiomyopathy | 0.71390224 |
| 127 | MP0001881_abnormal_mammary_gland | 0.68160940 |
| 128 | MP0005621_abnormal_cell_physiology | 0.67074879 |
| 129 | MP0002177_abnormal_outer_ear | 0.64546513 |
| 130 | MP0009697_abnormal_copulation | 0.63323913 |
| 131 | MP0000358_abnormal_cell_content/ | 0.63130384 |
| 132 | MP0002108_abnormal_muscle_morphology | 0.62801819 |
| 133 | MP0003755_abnormal_palate_morphology | 0.62112974 |
| 134 | MP0008007_abnormal_cellular_replicative | 0.60835267 |
| 135 | MP0000534_abnormal_ureter_morphology | 0.58291614 |
| 136 | * MP0001614_abnormal_blood_vessel | 0.57507591 |
| 137 | MP0005409_darkened_coat_color | 0.56768771 |
| 138 | MP0003385_abnormal_body_wall | 0.56450272 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Premature rupture of membranes (HP:0001788) | 5.17316243 |
| 2 | Protrusio acetabuli (HP:0003179) | 4.79515706 |
| 3 | Atrophic scars (HP:0001075) | 4.58695111 |
| 4 | Reduced subcutaneous adipose tissue (HP:0003758) | 3.83146661 |
| 5 | Popliteal pterygium (HP:0009756) | 3.67713614 |
| 6 | Amniotic constriction ring (HP:0009775) | 3.61167198 |
| 7 | Abnormality of placental membranes (HP:0011409) | 3.61167198 |
| 8 | Spondylolisthesis (HP:0003302) | 3.57825437 |
| 9 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 3.39482643 |
| 10 | Osteolytic defects of the hand bones (HP:0009699) | 3.39482643 |
| 11 | Cervical subluxation (HP:0003308) | 3.37526381 |
| 12 | Increased connective tissue (HP:0009025) | 3.28206570 |
| 13 | Vertebral compression fractures (HP:0002953) | 3.23479584 |
| 14 | Peritonitis (HP:0002586) | 3.20684274 |
| 15 | Milia (HP:0001056) | 3.15461854 |
| 16 | Fragile skin (HP:0001030) | 3.15372646 |
| 17 | Right ventricular cardiomyopathy (HP:0011663) | 3.11116298 |
| 18 | Ankle contracture (HP:0006466) | 3.03889315 |
| 19 | Glucose intolerance (HP:0000833) | 3.02920716 |
| 20 | Fragile nails (HP:0001808) | 2.98724030 |
| 21 | Aortic dissection (HP:0002647) | 2.98259918 |
| 22 | Short nail (HP:0001799) | 2.95816815 |
| 23 | Neonatal short-limb short stature (HP:0008921) | 2.89642554 |
| 24 | Spinal rigidity (HP:0003306) | 2.89482735 |
| 25 | Cardiovascular calcification (HP:0011915) | 2.88700376 |
| 26 | Alopecia of scalp (HP:0002293) | 2.85315928 |
| 27 | Thick nail (HP:0001805) | 2.82746602 |
| 28 | Wormian bones (HP:0002645) | 2.81134582 |
| 29 | Onycholysis (HP:0001806) | 2.81127364 |
| 30 | Dilatation of the ascending aorta (HP:0005111) | 2.79092659 |
| 31 | Aortic aneurysm (HP:0004942) | 2.75537825 |
| 32 | Soft skin (HP:0000977) | 2.74141716 |
| 33 | Follicular hyperkeratosis (HP:0007502) | 2.73932342 |
| 34 | Plantar hyperkeratosis (HP:0007556) | 2.69214690 |
| 35 | Shallow orbits (HP:0000586) | 2.65665456 |
| 36 | Distal lower limb muscle weakness (HP:0009053) | 2.65088974 |
| 37 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.61576082 |
| 38 | Entropion (HP:0000621) | 2.57690719 |
| 39 | Abnormality of dentin (HP:0010299) | 2.55151822 |
| 40 | Abnormalities of placenta or umbilical cord (HP:0001194) | 2.51395661 |
| 41 | Cerebral aneurysm (HP:0004944) | 2.49487673 |
| 42 | Mitral stenosis (HP:0001718) | 2.44848426 |
| 43 | Cupped ribs (HP:0000887) | 2.44744012 |
| 44 | Eczematoid dermatitis (HP:0000976) | 2.36334834 |
| 45 | Abnormality of the umbilical cord (HP:0010881) | 2.35786340 |
| 46 | Vascular calcification (HP:0004934) | 2.33411312 |
| 47 | Flat acetabular roof (HP:0003180) | 2.27432572 |
| 48 | Interstitial pulmonary disease (HP:0006530) | 2.19121177 |
| 49 | Generalized amyotrophy (HP:0003700) | 2.18979579 |
| 50 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.17264318 |
| 51 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.17264318 |
| 52 | Abnormality of glycolipid metabolism (HP:0010969) | 2.17264318 |
| 53 | Blue sclerae (HP:0000592) | 2.17208472 |
| 54 | Type 1 muscle fiber predominance (HP:0003803) | 2.16275716 |
| 55 | Nail dystrophy (HP:0008404) | 2.15686306 |
| 56 | Coxa vara (HP:0002812) | 2.14214661 |
| 57 | Natal tooth (HP:0000695) | 2.13931905 |
| 58 | Epiphyseal dysplasia (HP:0002656) | 2.12493778 |
| 59 | Vascular tortuosity (HP:0004948) | 2.10363057 |
| 60 | Abnormality of the neuromuscular junction (HP:0003398) | 2.10142656 |
| 61 | Fatigable weakness (HP:0003473) | 2.10142656 |
| 62 | Abnormal hemoglobin (HP:0011902) | 2.09957487 |
| 63 | Delayed gross motor development (HP:0002194) | 2.09535078 |
| 64 | Aortic valve stenosis (HP:0001650) | 2.05749365 |
| 65 | Elbow flexion contracture (HP:0002987) | 2.05621240 |
| 66 | Microglossia (HP:0000171) | 2.01148865 |
| 67 | Beaking of vertebral bodies (HP:0004568) | 1.99971788 |
| 68 | Syringomyelia (HP:0003396) | 1.99754853 |
| 69 | Spinal cord lesions (HP:0100561) | 1.99754853 |
| 70 | Mitral regurgitation (HP:0001653) | 1.99209478 |
| 71 | Broad metatarsal (HP:0001783) | 1.98968575 |
| 72 | Abnormal glucose tolerance (HP:0001952) | 1.98627467 |
| 73 | Biconcave vertebral bodies (HP:0004586) | 1.98257847 |
| 74 | Woolly hair (HP:0002224) | 1.97799184 |
| 75 | Palmoplantar hyperkeratosis (HP:0000972) | 1.97669713 |
| 76 | Aortic regurgitation (HP:0001659) | 1.97490240 |
| 77 | Trismus (HP:0000211) | 1.96489415 |
| 78 | Abnormality of the acetabulum (HP:0003170) | 1.95082920 |
| 79 | Rough bone trabeculation (HP:0100670) | 1.94303048 |
| 80 | Pterygium (HP:0001059) | 1.94068248 |
| 81 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.91414501 |
| 82 | Acanthosis nigricans (HP:0000956) | 1.90930566 |
| 83 | Hypotrichosis (HP:0001006) | 1.90781826 |
| 84 | Axonal loss (HP:0003447) | 1.90702498 |
| 85 | Mitral valve prolapse (HP:0001634) | 1.90487543 |
| 86 | Genu recurvatum (HP:0002816) | 1.89557003 |
| 87 | Ulnar bowing (HP:0003031) | 1.89237003 |
| 88 | Radial bowing (HP:0002986) | 1.88797016 |
| 89 | Platyspondyly (HP:0000926) | 1.88482649 |
| 90 | Orthostatic hypotension (HP:0001278) | 1.88012889 |
| 91 | Abnormality of carpal bone ossification (HP:0006257) | 1.87287500 |
| 92 | Distal lower limb amyotrophy (HP:0008944) | 1.84027792 |
| 93 | Abnormality of the 2nd finger (HP:0004100) | 1.83707389 |
| 94 | Recurrent abscess formation (HP:0002722) | 1.83221895 |
| 95 | Scapular winging (HP:0003691) | 1.82636039 |
| 96 | Aplasia of the musculature (HP:0100854) | 1.82432171 |
| 97 | Myocardial infarction (HP:0001658) | 1.82034549 |
| 98 | Wrist flexion contracture (HP:0001239) | 1.81044862 |
| 99 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 1.80772112 |
| 100 | Sparse eyelashes (HP:0000653) | 1.80566286 |
| 101 | Spinal cord compression (HP:0002176) | 1.80130588 |
| 102 | Hand muscle atrophy (HP:0009130) | 1.79827051 |
| 103 | Thin bony cortex (HP:0002753) | 1.79117957 |
| 104 | Palmar hyperkeratosis (HP:0010765) | 1.78797901 |
| 105 | Abnormal vertebral ossification (HP:0100569) | 1.78782898 |
| 106 | Arterial tortuosity (HP:0005116) | 1.77996722 |
| 107 | Osteoarthritis (HP:0002758) | 1.77775355 |
| 108 | Mesomelia (HP:0003027) | 1.76556279 |
| 109 | Ovoid vertebral bodies (HP:0003300) | 1.76037074 |
| 110 | Limb-girdle muscle atrophy (HP:0003797) | 1.74967967 |
| 111 | Broad face (HP:0000283) | 1.74865276 |
| 112 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.74429810 |
| 113 | Orchitis (HP:0100796) | 1.74189985 |
| 114 | Bladder diverticulum (HP:0000015) | 1.73447716 |
| 115 | Abnormality of the calcaneus (HP:0008364) | 1.73388840 |
| 116 | Nuclear cataract (HP:0100018) | 1.73321727 |
| 117 | Thoracolumbar scoliosis (HP:0002944) | 1.73167057 |
| 118 | Abnormality of oral frenula (HP:0000190) | 1.72744067 |
| 119 | Difficulty climbing stairs (HP:0003551) | 1.72412737 |
| 120 | Myositis (HP:0100614) | 1.71933787 |
| 121 | Camptodactyly of toe (HP:0001836) | 1.69901053 |
| 122 | Autoimmune thrombocytopenia (HP:0001973) | 1.69403062 |
| 123 | Subacute progressive viral hepatitis (HP:0006572) | 1.69392590 |
| 124 | Distal upper limb amyotrophy (HP:0007149) | 1.69284841 |
| 125 | Upper limb amyotrophy (HP:0009129) | 1.69284841 |
| 126 | Abnormal delivery (HP:0001787) | 1.69270788 |
| 127 | Asymmetry of the thorax (HP:0001555) | 1.67702414 |
| 128 | Femoral bowing (HP:0002980) | 1.67431140 |
| 129 | Hydroxyprolinuria (HP:0003080) | 1.66878630 |
| 130 | Abnormality of proline metabolism (HP:0010907) | 1.66878630 |
| 131 | Nemaline bodies (HP:0003798) | 1.66575595 |
| 132 | Advanced eruption of teeth (HP:0006288) | 1.66366905 |
| 133 | Delayed cranial suture closure (HP:0000270) | 1.65986974 |
| 134 | Pustule (HP:0200039) | 1.65850385 |
| 135 | Joint laxity (HP:0001388) | 1.65692223 |
| 136 | Absent frontal sinuses (HP:0002688) | 1.65517805 |
| 137 | Selective tooth agenesis (HP:0001592) | 1.65516350 |
| 138 | Abnormal foot bone ossification (HP:0010675) | 1.65193806 |
| 139 | Vertebral hypoplasia (HP:0008417) | 1.65038729 |
| 140 | Aplasia/Hypoplasia of the vertebrae (HP:0008515) | 1.65038729 |
| 141 | Hematochezia (HP:0002573) | 1.64494432 |
| 142 | Abnormality of nail color (HP:0100643) | 1.64192808 |
| 143 | Tibial bowing (HP:0002982) | 1.63301434 |
| 144 | Joint stiffness (HP:0001387) | 1.62930623 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K12 | 3.89596738 |
| 2 | TESK1 | 3.09143840 |
| 3 | MST1R | 2.86288557 |
| 4 | MAP3K3 | 2.81369749 |
| 5 | TRIB3 | 2.73076543 |
| 6 | TRPM7 | 2.68408466 |
| 7 | PIM2 | 2.57503410 |
| 8 | TTN | 2.54421614 |
| 9 | EPHA2 | 2.50953284 |
| 10 | MST4 | 2.44961818 |
| 11 | DDR2 | 2.28636306 |
| 12 | LIMK1 | 2.26456429 |
| 13 | LRRK2 | 2.16326917 |
| 14 | EIF2AK1 | 2.11813612 |
| 15 | ERBB3 | 2.06821669 |
| 16 | ERN1 | 2.03931106 |
| 17 | EPHB2 | 2.00225341 |
| 18 | NME2 | 1.95062549 |
| 19 | EIF2AK3 | 1.87649794 |
| 20 | MAP3K14 | 1.84200352 |
| 21 | NEK9 | 1.78338253 |
| 22 | FER | 1.75328711 |
| 23 | STK10 | 1.73289766 |
| 24 | ERBB4 | 1.72696232 |
| 25 | NEK1 | 1.68290448 |
| 26 | TBK1 | 1.65403914 |
| 27 | MAPKAPK3 | 1.62911666 |
| 28 | RPS6KA4 | 1.60301892 |
| 29 | RIPK1 | 1.53453323 |
| 30 | PTK6 | 1.45393747 |
| 31 | BLK | 1.45218366 |
| 32 | MET | 1.43000610 |
| 33 | LATS1 | 1.40593630 |
| 34 | MOS | 1.40275174 |
| 35 | PBK | 1.40144326 |
| 36 | PTK2 | 1.36966031 |
| 37 | TGFBR2 | 1.35959284 |
| 38 | PKN2 | 1.30948279 |
| 39 | CDK8 | 1.30569742 |
| 40 | FRK | 1.29370299 |
| 41 | MUSK | 1.29342966 |
| 42 | LATS2 | 1.29223983 |
| 43 | BUB1 | 1.29099351 |
| 44 | BMX | 1.25631087 |
| 45 | SIK3 | 1.21196752 |
| 46 | EPHB1 | 1.20100139 |
| 47 | PDK2 | 1.20034151 |
| 48 | PAK4 | 1.16067293 |
| 49 | EPHA3 | 1.14628432 |
| 50 | PDGFRA | 1.14139232 |
| 51 | MAP2K1 | 1.13754696 |
| 52 | JAK3 | 1.13390460 |
| 53 | SCYL2 | 1.12476188 |
| 54 | TYK2 | 1.12031736 |
| 55 | MAP3K2 | 1.11401958 |
| 56 | PRKG2 | 1.10228271 |
| 57 | TRIM28 | 1.08530169 |
| 58 | MAP2K3 | 1.06036549 |
| 59 | STK24 | 1.04836655 |
| 60 | STK3 | 1.04168412 |
| 61 | NTRK1 | 1.03361819 |
| 62 | RPS6KB2 | 1.02917641 |
| 63 | ILK | 1.01296716 |
| 64 | TESK2 | 0.99007109 |
| 65 | FLT3 | 0.97390548 |
| 66 | MAP3K11 | 0.97013485 |
| 67 | IKBKB | 0.93446935 |
| 68 | MAP2K2 | 0.93378316 |
| 69 | PAK2 | 0.91305983 |
| 70 | KDR | 0.86992056 |
| 71 | TGFBR1 | 0.84533324 |
| 72 | STK38L | 0.83420509 |
| 73 | MAPKAPK2 | 0.75392360 |
| 74 | JAK1 | 0.75210926 |
| 75 | MYLK | 0.71761595 |
| 76 | MELK | 0.71153069 |
| 77 | ABL2 | 0.70150464 |
| 78 | CSK | 0.70148253 |
| 79 | ROCK1 | 0.69361729 |
| 80 | GRK7 | 0.69324828 |
| 81 | MATK | 0.69181264 |
| 82 | FGFR3 | 0.68942195 |
| 83 | FGFR4 | 0.68554282 |
| 84 | CHUK | 0.68175901 |
| 85 | PTK2B | 0.65709133 |
| 86 | VRK2 | 0.62583850 |
| 87 | CDK6 | 0.62472005 |
| 88 | PIK3CG | 0.62218409 |
| 89 | BMPR2 | 0.62098952 |
| 90 | SIK1 | 0.60703801 |
| 91 | ZAP70 | 0.60107706 |
| 92 | PDGFRB | 0.59114411 |
| 93 | DAPK3 | 0.57831109 |
| 94 | IKBKE | 0.57015627 |
| 95 | FGFR1 | 0.56783842 |
| 96 | STK38 | 0.56575445 |
| 97 | PAK6 | 0.56566859 |
| 98 | BRSK2 | 0.55784578 |
| 99 | ARAF | 0.53782478 |
| 100 | DAPK1 | 0.53747121 |
| 101 | MAP3K8 | 0.53395864 |
| 102 | PIK3CA | 0.49965243 |
| 103 | LMTK2 | 0.49097652 |
| 104 | BRSK1 | 0.48659714 |
| 105 | DMPK | 0.48054825 |
| 106 | TAOK1 | 0.47786099 |
| 107 | PRKCI | 0.47585939 |
| 108 | EEF2K | 0.46089286 |
| 109 | PAK1 | 0.45773934 |
| 110 | NUAK1 | 0.44037150 |
| 111 | RIPK4 | 0.43955347 |
| 112 | ABL1 | 0.43429645 |
| 113 | PAK3 | 0.43359955 |
| 114 | STK16 | 0.42648428 |
| 115 | GSK3A | 0.42501322 |
| 116 | PLK2 | 0.41855322 |
| 117 | IRAK3 | 0.40857727 |
| 118 | TAOK2 | 0.40133061 |
| 119 | BCR | 0.40010985 |
| 120 | HCK | 0.37948578 |
| 121 | PRKD2 | 0.37369654 |
| 122 | INSR | 0.37238275 |
| 123 | PIM1 | 0.36745715 |
| 124 | MAP3K1 | 0.36509367 |
| 125 | TIE1 | 0.36476363 |
| 126 | IGF1R | 0.35880786 |
| 127 | CDK9 | 0.35631343 |
| 128 | ROCK2 | 0.35132954 |
| 129 | KSR1 | 0.34974904 |
| 130 | KIT | 0.33658826 |
| 131 | CAMK2D | 0.31957226 |
| 132 | EIF2AK2 | 0.31636269 |
| 133 | CAMK2G | 0.31244382 |
| 134 | ADRBK1 | 0.31103692 |
| 135 | ZAK | 0.31039905 |
| 136 | AURKB | 0.29765479 |
| 137 | PRKCE | 0.28285393 |
| 138 | PLK3 | 0.27523698 |
| 139 | AKT2 | 0.24642540 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ECM-receptor interaction_Homo sapiens_hsa04512 | 2.86890296 |
| 2 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 2.54947346 |
| 3 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.46404036 |
| 4 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 2.25899843 |
| 5 | Malaria_Homo sapiens_hsa05144 | 2.14503251 |
| 6 | Leishmaniasis_Homo sapiens_hsa05140 | 2.10177918 |
| 7 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 2.03429969 |
| 8 | Focal adhesion_Homo sapiens_hsa04510 | 2.02202646 |
| 9 | Adherens junction_Homo sapiens_hsa04520 | 1.99973636 |
| 10 | Amoebiasis_Homo sapiens_hsa05146 | 1.89396628 |
| 11 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.86091539 |
| 12 | Shigellosis_Homo sapiens_hsa05131 | 1.85364408 |
| 13 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.84517751 |
| 14 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.81345575 |
| 15 | Viral myocarditis_Homo sapiens_hsa05416 | 1.78512784 |
| 16 | Salmonella infection_Homo sapiens_hsa05132 | 1.76658357 |
| 17 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.74541732 |
| 18 | Pertussis_Homo sapiens_hsa05133 | 1.72797872 |
| 19 | Legionellosis_Homo sapiens_hsa05134 | 1.72707812 |
| 20 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.71418390 |
| 21 | Protein export_Homo sapiens_hsa03060 | 1.69947121 |
| 22 | Galactose metabolism_Homo sapiens_hsa00052 | 1.66708695 |
| 23 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.65804344 |
| 24 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.65014588 |
| 25 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.63989801 |
| 26 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.61173173 |
| 27 | Phagosome_Homo sapiens_hsa04145 | 1.58124196 |
| 28 | Apoptosis_Homo sapiens_hsa04210 | 1.55777206 |
| 29 | Bladder cancer_Homo sapiens_hsa05219 | 1.52889359 |
| 30 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.48699775 |
| 31 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.46985439 |
| 32 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.37740551 |
| 33 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.34273776 |
| 34 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.32248964 |
| 35 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.28299112 |
| 36 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 1.28173229 |
| 37 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.27092543 |
| 38 | Tuberculosis_Homo sapiens_hsa05152 | 1.24455320 |
| 39 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.24124708 |
| 40 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.23984515 |
| 41 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.20788482 |
| 42 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.19867778 |
| 43 | Hippo signaling pathway_Homo sapiens_hsa04390 | 1.18845194 |
| 44 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.17641851 |
| 45 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.15941365 |
| 46 | Allograft rejection_Homo sapiens_hsa05330 | 1.14678406 |
| 47 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.13250154 |
| 48 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.12514174 |
| 49 | Lysosome_Homo sapiens_hsa04142 | 1.10528980 |
| 50 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.08868665 |
| 51 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.08499552 |
| 52 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 1.08253181 |
| 53 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.07109141 |
| 54 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.05796066 |
| 55 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.04148552 |
| 56 | Influenza A_Homo sapiens_hsa05164 | 1.02804087 |
| 57 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.02775265 |
| 58 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.02643237 |
| 59 | Thyroid cancer_Homo sapiens_hsa05216 | 1.02518137 |
| 60 | Platelet activation_Homo sapiens_hsa04611 | 1.02157948 |
| 61 | Measles_Homo sapiens_hsa05162 | 1.01891152 |
| 62 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.01841828 |
| 63 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.01627834 |
| 64 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.98950245 |
| 65 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.98946111 |
| 66 | Mineral absorption_Homo sapiens_hsa04978 | 0.96572818 |
| 67 | Tight junction_Homo sapiens_hsa04530 | 0.95259977 |
| 68 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.95087886 |
| 69 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.92083738 |
| 70 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.92003332 |
| 71 | Hepatitis B_Homo sapiens_hsa05161 | 0.91074449 |
| 72 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.90144745 |
| 73 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.89438530 |
| 74 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.88551768 |
| 75 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.85312813 |
| 76 | Proteasome_Homo sapiens_hsa03050 | 0.84210530 |
| 77 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.82092278 |
| 78 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.81819073 |
| 79 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.81677606 |
| 80 | Hepatitis C_Homo sapiens_hsa05160 | 0.80158581 |
| 81 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.79889916 |
| 82 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.79523202 |
| 83 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.79301987 |
| 84 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.78175029 |
| 85 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.78113468 |
| 86 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.77928857 |
| 87 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.77537990 |
| 88 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.77260328 |
| 89 | Melanoma_Homo sapiens_hsa05218 | 0.75198778 |
| 90 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.75181779 |
| 91 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.74724341 |
| 92 | HTLV-I infection_Homo sapiens_hsa05166 | 0.74671515 |
| 93 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.73238212 |
| 94 | Pathways in cancer_Homo sapiens_hsa05200 | 0.73084324 |
| 95 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.71539831 |
| 96 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.71366789 |
| 97 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.71104026 |
| 98 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.70104621 |
| 99 | Carbon metabolism_Homo sapiens_hsa01200 | 0.67597294 |
| 100 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.66184879 |
| 101 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.65151935 |
| 102 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.64645781 |
| 103 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.62952842 |
| 104 | Ribosome_Homo sapiens_hsa03010 | 0.62802396 |
| 105 | Prostate cancer_Homo sapiens_hsa05215 | 0.62717032 |
| 106 | Endocytosis_Homo sapiens_hsa04144 | 0.62287710 |
| 107 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.61219849 |
| 108 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.59997374 |
| 109 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.59724140 |
| 110 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.58171742 |
| 111 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.57587729 |
| 112 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.57340327 |
| 113 | Other glycan degradation_Homo sapiens_hsa00511 | 0.56961663 |
| 114 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.55754524 |
| 115 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.55591214 |
| 116 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.55272670 |
| 117 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.53243635 |
| 118 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.52984642 |
| 119 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.52005997 |
| 120 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.51653244 |
| 121 | Endometrial cancer_Homo sapiens_hsa05213 | 0.51598358 |
| 122 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.50480628 |
| 123 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.50464379 |
| 124 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.49165202 |
| 125 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.49045534 |
| 126 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.45056895 |
| 127 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.44097615 |
| 128 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.43997942 |
| 129 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.40001638 |
| 130 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.34973737 |
| 131 | Axon guidance_Homo sapiens_hsa04360 | 0.34859397 |
| 132 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.33920430 |
| 133 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.28019032 |
| 134 | Prion diseases_Homo sapiens_hsa05020 | 0.26674812 |
| 135 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.26580387 |
| 136 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.26438660 |
| 137 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.25293386 |
| 138 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.22359964 |
| 139 | Cell cycle_Homo sapiens_hsa04110 | 0.21345420 |

